Log in

NASDAQ:VIVEViveve Medical Stock Price, Forecast & News

-0.03 (-4.94 %)
(As of 08/11/2020 04:00 PM ET)
Today's Range
Now: $0.61
50-Day Range
MA: $0.59
52-Week Range
Now: $0.61
Volume567,794 shs
Average Volume1.55 million shs
Market Capitalization$9.49 million
P/E RatioN/A
Dividend YieldN/A
Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Read More
Viveve Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.85 out of 5 stars

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolNASDAQ:VIVE
Previous SymbolOTCMKTS:PLCSD



Sales & Book Value

Annual Sales$6.57 million
Book Value$2.34 per share


Net Income$-42,530,000.00
Net Margins-822.47%
Return on Equity-25,840.09%


Market Cap$9.49 million
Next Earnings Date8/13/2020 (Confirmed)
-0.03 (-4.94 %)
(As of 08/11/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VIVE News and Ratings via Email

Sign-up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Viveve Medical (NASDAQ:VIVE) Frequently Asked Questions

How has Viveve Medical's stock been impacted by COVID-19 (Coronavirus)?

Viveve Medical's stock was trading at $0.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VIVE shares have decreased by 27.8% and is now trading at $0.6064.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of Viveve Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Viveve Medical

When is Viveve Medical's next earnings date?

Viveve Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020.
View our earnings forecast for Viveve Medical

How can I listen to Viveve Medical's earnings call?

Viveve Medical will be holding an earnings conference call on Thursday, August 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Viveve Medical's earnings last quarter?

Viveve Medical Inc (NASDAQ:VIVE) posted its quarterly earnings results on Thursday, May, 14th. The company reported ($0.82) earnings per share (EPS) for the quarter, beating the consensus estimate of ($12.60) by $11.78. The firm earned $1.30 million during the quarter. Viveve Medical had a negative return on equity of 25,840.09% and a negative net margin of 822.47%.
View Viveve Medical's earnings history

Has Viveve Medical been receiving favorable news coverage?

News coverage about VIVE stock has been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Viveve Medical earned a news impact score of 1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Viveve Medical

Are investors shorting Viveve Medical?

Viveve Medical saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 193,000 shares, an increase of 25.0% from the January 31st total of 154,400 shares. Based on an average trading volume of 2,430,000 shares, the short-interest ratio is presently 0.1 days. Approximately 4.8% of the company's shares are short sold.
View Viveve Medical's Short Interest

Who are some of Viveve Medical's key competitors?

What other stocks do shareholders of Viveve Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Inovio Pharmaceuticals (INO), Western Digital (WDC), Novavax (NVAX) and Selecta Biosciences (SELB).

Who are Viveve Medical's key executives?

Viveve Medical's management team includes the following people:
  • Mr. Scott C. Durbin, CEO & Director (Age 50)
  • Mr. James Gregory Atkinson, Chief Bus. Officer & Pres (Age 61)
  • Mr. Jim B. Robbins, VP of Fin. & Admin., Principal Accounting Officer and Principal Financial Officer (Age 55)
  • Ms. Deborah A. Jorn, Sr. Advisor to the CEO & Director (Age 61)
  • Mr. Martin Kerber, VP of Operations

When did Viveve Medical IPO?

(VIVE) raised $13 million in an IPO on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.

What is Viveve Medical's stock symbol?

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

How do I buy shares of Viveve Medical?

Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Viveve Medical's stock price today?

One share of VIVE stock can currently be purchased for approximately $0.61.

How big of a company is Viveve Medical?

Viveve Medical has a market capitalization of $9.49 million and generates $6.57 million in revenue each year. The company earns $-42,530,000.00 in net income (profit) each year or ($33.80) on an earnings per share basis. Viveve Medical employs 67 workers across the globe.

What is Viveve Medical's official website?

The official website for Viveve Medical is www.viveve.com.

How can I contact Viveve Medical?

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.